Inhibition of the Human Immunodeficiency Virus Type 1 DNA Integration by Modified Oligonucleotides

被引:0
|
作者
M. D. Pinskaya
P. Brodin
E. A. Romanova
E. M. Volkov
J.-F. Mouscadet
M. B. Gottikh
机构
[1] Moscow State University,Chemical Faculty
[2] CNRS-UMR 8532,Belozersky Institute of Physico
[3] Institut Gustave Roussy,Chemical Biology
[4] Moscow State University,undefined
来源
Molecular Biology | 2000年 / 34卷
关键词
HIV-1; integration; oligonucleotide; quadruplex; triplex-forming oligonucleotide; parallel duplex; phosphorothioate oligonucleotide;
D O I
暂无
中图分类号
学科分类号
摘要
Oligonucleotide inhibitors of the HIV-1 DNA integration identified to date are reviewed. Two basic strategies of blocking the integration are considered: shielding the integrase-binding sites on the viral DNA by triplex-forming oligonucleotides, and directly inhibiting the enzyme with oligonucleotide agents.
引用
收藏
页码:888 / 894
页数:6
相关论文
共 50 条
  • [11] A sensitive, quantitative assay for human immunodeficiency virus type 1 integration
    O'Doherty, U
    Swiggard, WJ
    Jeyakumar, D
    McGain, D
    Malim, MH
    JOURNAL OF VIROLOGY, 2002, 76 (21) : 10942 - 10950
  • [12] Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro
    Gao, K
    Gorelick, RJ
    Johnson, DG
    Bushman, F
    JOURNAL OF VIROLOGY, 2003, 77 (02) : 1598 - 1603
  • [13] Human cell proteins and human immunodeficiency virus DNA integration
    Turlure, F
    Devroe, E
    Silver, PA
    Engelman, A
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 3187 - 3208
  • [14] SPECIFIC-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY ANTISENSE OLIGONUCLEOTIDES - AN INVITRO MODEL FOR TREATMENT
    LISZIEWICZ, J
    SUN, D
    KLOTMAN, M
    AGRAWAL, S
    ZAMECNIK, P
    GALLO, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11209 - 11213
  • [15] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VITRO BY OLIGONUCLEOTIDES COMPOSED ENTIRELY OF GUANOSINE AND THYMIDINE
    OJWANG, J
    ELBAGGARI, A
    MARSHALL, HB
    JAYARAMAN, K
    MCGRATH, MS
    RANDO, RF
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (06): : 560 - 570
  • [16] Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
    Irene Guendel
    Emmanuel T Agbottah
    Kylene Kehn-Hall
    Fatah Kashanchi
    AIDS Research and Therapy, 7
  • [17] Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate
    Wang, Xiaoli
    Wang, Jiao
    Zhang, Wenmei
    Li, Boye
    Zhu, Ying
    Hu, Qin
    Yang, Yishu
    Zhang, Xiaoguang
    Yan, Hong
    Zeng, Yi
    VIRUSES-BASEL, 2018, 10 (05):
  • [18] Human immunodeficiency virus type 1 cDNA integration: New aromatic hydroxylated inhibitors and studies of the inhibition mechanism
    Farnet, CM
    Wang, B
    Hansen, M
    Lipford, JR
    Zalkow, L
    Robinson, WE
    Siegel, J
    Bushman, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2245 - 2253
  • [19] Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance
    Zahm, Jacob A.
    Bera, Sibes
    Pandey, Krishan K.
    Vora, Ajaykumar
    Stillmock, Kara
    Hazuda, Daria
    Grandgenett, Duane P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) : 3358 - 3368
  • [20] Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
    Guendel, Irene
    Agbottah, Emmanuel T.
    Kehn-Hall, Kylene
    Kashanchi, Fatah
    AIDS RESEARCH AND THERAPY, 2010, 7